Pondchy pioneered the concept of commercialzing PFIs or Pre formulation Intermediates, with objective to reduce cost economics of products and to enable ease of operations for the Manufacturer.

PFI’s enable “drum to hopper to compression / encapsulation,” which offer cost and quality advantages on the supply chain, testing, technical and capital resources fronts at finished dosage manufacturer’s site.

We work on identifying and scaling up PFIs for molecules that have a sustainable market presence and focus on bringing in continuous cost effeciencies.

• Metformin DC granules constitutes high active load..
• Good flow, High compressibility, Optimal mechanical strength and Controlled drug release for extended period of time.
• Involves time-tested MATRIX platform technology to ensure reproducibility and robustness in extended drug delivery between batch to batch.
• Saves time, cost and resources for the customer company to meet the ever-growing market demand of Metformin ER and Metformin ER combo products.